8.62 USD
+0.04
0.47%
Updated Apr 2, 12:02 PM EDT
1 day
0.47%
5 days
-13.28%
1 month
0.47%
3 months
36.83%
6 months
-8.30%
Year to date
36.83%
1 year
-25.69%
5 years
-86.96%
10 years
-93.75%
 

About: 111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Employees: 1,520

0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

818% more capital invested

Capital invested by funds: $242K [Q3] → $2.23M (+$1.98M) [Q4]

122% more funds holding

Funds holding: 9 [Q3] → 20 (+11) [Q4]

2.77% more ownership

Funds ownership: 0.32% [Q3] → 3.1% (+2.77%) [Q4]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Research analyst outlook

We haven’t received any recent analyst ratings for YI.

Financial journalist opinion

Based on 3 articles about YI published over the past 30 days

Neutral
Seeking Alpha
1 week ago
111, Inc. (YI) Q4 2024 Earnings Call Transcript
111, Inc. (NASDAQ:YI ) Q4 2024 Earnings Conference Call March 20, 2025 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Robert Sassoon - Water Tower Research Shifan Sun - CICC Zoe Bian - Citi Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
111, Inc. (YI) Q4 2024 Earnings Call Transcript
Neutral
PRNewsWire
1 week ago
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Achieved First-Ever Annual Operating Profit Bottom Line Improved by RMB332.7 Million YoY in 2024 Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoY Achieved First-Ever Annual Positive Operating Cash Flow SHANGHAI , March 20, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Net revenues were RMB3.8 billion (US$527.1 million) and gross segment profit (1) was RMB202.5 million (US$27.7 million).
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Neutral
PRNewsWire
3 weeks ago
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
SHANGHAI , March 12, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, March 26, 2025 at 11:00 a.m. ET. Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q4 2024 earnings (to be reported on Thursday, March 20, 2024), its priorities and goals for 2025, and an updated overview of the macroenvironment.
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
Neutral
PRNewsWire
1 month ago
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
SHANGHAI , Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 20, 2025 (7:30 PM Beijing Time on the same day).
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
Neutral
PRNewsWire
1 month ago
111, Inc. Regains Compliance with NASDAQ Requirement
SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a  leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that Nasdaq has determined that for the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the Company's American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1).
111, Inc. Regains Compliance with NASDAQ Requirement
Neutral
GlobeNewsWire
2 months ago
Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc.
Compound Semiconductor Industry size is expected to register 10.9% CAGR between 2024 and 2032 propelled by electric vehicles and renewable energy. Compound Semiconductor Industry size is expected to register 10.9% CAGR between 2024 and 2032 propelled by electric vehicles and renewable energy.
Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc.
Neutral
PRNewsWire
2 months ago
111, Inc. Announces ADS Ratio Change
SHANGHAI , Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares from one (1) ADS representing two (2) Class A ordinary shares to the new ratio of one (1) ADS representing twenty (20) Class A ordinary shares. For the Company's ADS holders, this ratio change will have the same effect as a one-for-ten reverse ADS split.
111, Inc. Announces ADS Ratio Change
Neutral
Seeking Alpha
4 months ago
111, Inc. (YI) Q3 2024 Earnings Call Transcript
111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
111, Inc. (YI) Q3 2024 Earnings Call Transcript
Neutral
PRNewsWire
4 months ago
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI , Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Net revenues were RMB3.6 billion (US$513.1 million), remaining relatively flat compared to the same quarter last year.
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Neutral
PRNewsWire
4 months ago
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Friday, December 6, 2024 at 11:00 a.m. ET. Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q3 2024 earnings (to be reported on Wednesday, November 27, 2024), along with challenges, opportunities, and the NASDAQ share price compliance issue.
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
Charts implemented using Lightweight Charts™